<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T02:15:41Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9896541" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9896541</identifier>
        <datestamp>2023-02-04</datestamp>
        <setSpec>sageopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Neurorehabil Neural Repair</journal-id>
              <journal-id journal-id-type="iso-abbrev">Neurorehabil Neural Repair</journal-id>
              <journal-id journal-id-type="publisher-id">NNR</journal-id>
              <journal-id journal-id-type="hwp">spnnr</journal-id>
              <journal-title-group>
                <journal-title>Neurorehabilitation and Neural Repair</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1545-9683</issn>
              <issn pub-type="epub">1552-6844</issn>
              <publisher>
                <publisher-name>SAGE Publications</publisher-name>
                <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9896541</article-id>
              <article-id pub-id-type="pmcid">PMC9896541</article-id>
              <article-id pub-id-type="pmc-uid">9896541</article-id>
              <article-id pub-id-type="pmid">36636751</article-id>
              <article-id pub-id-type="pmid">36636751</article-id>
              <article-id pub-id-type="doi">10.1177/15459683221146995</article-id>
              <article-id pub-id-type="publisher-id">10.1177_15459683221146995</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Original Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Optimized Home Rehabilitation Technology Reduces Upper Extremity
Impairment Compared to a Conventional Home Exercise Program: A Randomized,
Controlled, Single-Blind Trial in Subacute Stroke</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4004-9397</contrib-id>
                  <name>
                    <surname>Swanson</surname>
                    <given-names>Veronica A.</given-names>
                  </name>
                  <degrees>MS</degrees>
                  <xref rid="aff1-15459683221146995" ref-type="aff">1</xref>
                  <xref rid="corresp1-15459683221146995" ref-type="corresp"/>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Johnson</surname>
                    <given-names>Christopher</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="aff2-15459683221146995" ref-type="aff">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Zondervan</surname>
                    <given-names>Daniel K.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff3-15459683221146995" ref-type="aff">3</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bayus</surname>
                    <given-names>Nicole</given-names>
                  </name>
                  <degrees>MA</degrees>
                  <xref rid="aff4-15459683221146995" ref-type="aff">4</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McCoy</surname>
                    <given-names>Phylicia</given-names>
                  </name>
                  <degrees>BS</degrees>
                  <xref rid="aff5-15459683221146995" ref-type="aff">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ng</surname>
                    <given-names>Yat Fung Joshua</given-names>
                  </name>
                  <degrees>BA</degrees>
                  <xref rid="aff6-15459683221146995" ref-type="aff">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Schindele, BS</surname>
                    <given-names>Jenna</given-names>
                  </name>
                  <xref rid="aff7-15459683221146995" ref-type="aff">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Reinkensmeyer</surname>
                    <given-names>David J.</given-names>
                  </name>
                  <degrees>PhD</degrees>
                  <xref rid="aff1-15459683221146995" ref-type="aff">1</xref>
                  <xref rid="aff8-15459683221146995" ref-type="aff">8</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shaw</surname>
                    <given-names>Susan</given-names>
                  </name>
                  <degrees>MD</degrees>
                  <xref rid="aff9-15459683221146995" ref-type="aff">9</xref>
                </contrib>
              </contrib-group>
              <aff id="aff1-15459683221146995"><label>1</label>Department of Mechanical and Aerospace
Engineering, Henry Samueli School of Engineering, University of California, Irvine,
Irvine, CA, USA</aff>
              <aff id="aff2-15459683221146995"><label>2</label>Department of Biomedical Engineering,
Henry Samueli School of Engineering, University of California, Irvine, Irvine, CA,
USA</aff>
              <aff id="aff3-15459683221146995"><label>3</label>Flint Rehabilitation Devices, LLC,
Irvine, CA, USA</aff>
              <aff id="aff4-15459683221146995"><label>4</label>Rancho Research Institute, Rancho Los
Amigos National Rehabilitation Hospital, Downey, USA</aff>
              <aff id="aff5-15459683221146995"><label>5</label>Arthur J. Bond Department of Mechanical
Engineering, Alabama A&amp;M University, Huntsville, AL, USA</aff>
              <aff id="aff6-15459683221146995"><label>6</label>School of Social Sciences, University
of California, Irvine, Irvine, CA, USA</aff>
              <aff id="aff7-15459683221146995"><label>7</label>Mathematics and Statistics, University
of California, Los Angeles, Los Angeles, CA, USA</aff>
              <aff id="aff8-15459683221146995"><label>8</label>Department of Anatomy and Neurobiology,
UC Irvine School of Medicine, University of California, Irvine, Irvine, CA,
USA</aff>
              <aff id="aff9-15459683221146995"><label>9</label>Department of Neurology, Rancho Los
Amigos National Rehabilitation Center, Downey, CA, USA</aff>
              <author-notes>
                <corresp id="corresp1-15459683221146995">Veronica A. Swanson, University of
California, Irvine, 3225 Engineering Gateway, Irvine, CA 92697-3975, USA. Email:
<email>swansonv@uci.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>12</day>
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>1</month>
                <year>2023</year>
              </pub-date>
              <volume>37</volume>
              <issue>1</issue>
              <fpage>53</fpage>
              <lpage>65</lpage>
              <permissions>
                <copyright-statement>© The Author(s) 2023</copyright-statement>
                <copyright-year>2023</copyright-year>
                <copyright-holder content-type="sage">American Society of
Neurorehabilitation</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This article is distributed under the terms of the Creative Commons
Attribution 4.0 License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>) which permits
any use, reproduction and distribution of the work without further
permission provided the original work is attributed as specified on the SAGE
and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
                </license>
              </permissions>
              <abstract>
                <sec id="section1-15459683221146995">
                  <title>Background</title>
                  <p>Upper extremity (UE) stroke rehabilitation requires patients to perform
exercises at home, yet patients show limited benefit from paper-based home
exercise programs.</p>
                </sec>
                <sec id="section2-15459683221146995">
                  <title>Objective</title>
                  <p>To compare the effectiveness of 2 home exercise programs for reducing UE
impairment: a paper-based approach and a sensorized exercise system that
incorporates recommended design features for home rehabilitation
technology.</p>
                </sec>
                <sec id="section3-15459683221146995">
                  <title>Methods</title>
                  <p>In this single-blind, randomized controlled trial, 27 participants in the
subacute phase of stroke were assigned to the sensorized exercise (n = 14)
or conventional therapy group (n = 13), though 2 participants in the
conventional therapy group were lost to follow-up. Participants were
instructed to perform self-guided movement training at home for at least
3 hours/week for 3 consecutive weeks. The sensorized exercise group used
FitMi, a computer game with 2 puck-like sensors that encourages movement
intensity and auto-progresses users through 40 exercises. The conventional
group used a paper book of exercises. The primary outcome measure was the
change in Upper Extremity Fugl–Meyer (UEFM) score from baseline to
follow-up. Secondary measures included the Modified Ashworth Scale for
spasticity (MAS) and the Visual Analog Pain (VAP) scale.</p>
                </sec>
                <sec id="section4-15459683221146995">
                  <title>Results</title>
                  <p>Participants who used FitMi improved by an average of 8.0 ± 4.6 points on the
UEFM scale compared to 3.0 ± 6.1 points for the conventional participants, a
significant difference (<italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> = .029).
FitMi participants exhibited no significant changes in UE MAS or VAP
scores.</p>
                </sec>
                <sec id="section5-15459683221146995">
                  <title>Conclusions</title>
                  <p>A sensor-based exercise system incorporating a suite of recommended design
features significantly and safely reduced UE impairment compared to a
paper-based, home exercise program.</p>
                </sec>
                <sec id="section6-15459683221146995">
                  <title>Trial Registration:</title>
                  <p>ClinicalTrials.gov Identifier: NCT03503617</p>
                </sec>
              </abstract>
              <kwd-group>
                <kwd>stroke</kwd>
                <kwd>rehabilitation</kwd>
                <kwd>exercise therapy</kwd>
                <kwd>home exercise program</kwd>
                <kwd>FitMi</kwd>
                <kwd>mRehab</kwd>
                <kwd>sensors</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group id="award1-15459683221146995">
                  <funding-source id="funding1-15459683221146995">
                    <institution-wrap>
                      <institution>National Institute on Aging</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000049</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding1-15459683221146995">R44AG059256</award-id>
                </award-group>
                <award-group id="award2-15459683221146995">
                  <funding-source id="funding2-15459683221146995">
                    <institution-wrap>
                      <institution>National Institute of Independent Living, Disability, and
Rehabilitation Research</institution>
                      <institution-id/>
                    </institution-wrap>
                  </funding-source>
                  <award-id rid="funding2-15459683221146995">90REGE0011</award-id>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>typesetter</meta-name>
                  <meta-value>ts1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="section7-15459683221146995">
              <title>Introduction</title>
              <p>Stroke is a leading cause of chronic disability in the United States.<sup><xref rid="bibr1-15459683221146995" ref-type="bibr">1</xref><xref rid="bibr2-15459683221146995" ref-type="bibr"/>-<xref rid="bibr3-15459683221146995" ref-type="bibr">3</xref></sup> Intensive upper extremity (UE)
rehabilitation can reduce long-term impairment after stroke<sup><xref rid="bibr4-15459683221146995" ref-type="bibr">4</xref><xref rid="bibr5-15459683221146995" ref-type="bibr"/><xref rid="bibr6-15459683221146995" ref-type="bibr"/><xref rid="bibr7-15459683221146995" ref-type="bibr"/><xref rid="bibr8-15459683221146995" ref-type="bibr"/>-<xref rid="bibr9-15459683221146995" ref-type="bibr">9</xref></sup> and is more effective when
delivered in the subacute phase following stroke.<sup><xref rid="bibr10-15459683221146995" ref-type="bibr">10</xref></sup> Though exact dose-response
relationships are unknown, recovery also appears to depend on the volume of movement
practice.<sup><xref rid="bibr11-15459683221146995" ref-type="bibr">11</xref><xref rid="bibr12-15459683221146995" ref-type="bibr"/><xref rid="bibr13-15459683221146995" ref-type="bibr"/><xref rid="bibr14-15459683221146995" ref-type="bibr"/>-<xref rid="bibr15-15459683221146995" ref-type="bibr">15</xref></sup> One-on-one supervised therapy
sessions are likely insufficient to achieve the required dose.<sup><xref rid="bibr16-15459683221146995" ref-type="bibr">16</xref>,<xref rid="bibr17-15459683221146995" ref-type="bibr">17</xref></sup> Home exercise
programs are prescribed to increase movement training dose, but the current standard
of care—following printed sheets of exercises—is associated with poor compliance,
poorer outcomes, and high dropout rates.<sup><xref rid="bibr18-15459683221146995" ref-type="bibr">18</xref><xref rid="bibr19-15459683221146995" ref-type="bibr"/><xref rid="bibr20-15459683221146995" ref-type="bibr"/><xref rid="bibr21-15459683221146995" ref-type="bibr"/><xref rid="bibr22-15459683221146995" ref-type="bibr"/>-<xref rid="bibr23-15459683221146995" ref-type="bibr">23</xref></sup></p>
              <p>Recognizing the need for sustainably increasing the amount of movement practice that
individuals undertake, there has been a surge in the development of technologies for
enabling individuals to practice on their own at home.<sup><xref rid="bibr20-15459683221146995" ref-type="bibr">20</xref>,<xref rid="bibr24-15459683221146995" ref-type="bibr">24</xref><xref rid="bibr25-15459683221146995" ref-type="bibr"/><xref rid="bibr26-15459683221146995" ref-type="bibr"/><xref rid="bibr27-15459683221146995" ref-type="bibr"/><xref rid="bibr28-15459683221146995" ref-type="bibr"/><xref rid="bibr29-15459683221146995" ref-type="bibr"/><xref rid="bibr30-15459683221146995" ref-type="bibr"/><xref rid="bibr31-15459683221146995" ref-type="bibr"/>-<xref rid="bibr32-15459683221146995" ref-type="bibr">32</xref></sup> Home-based technologies for
stroke rehabilitation include sensors, games, telerehabilitation, robotic devices,
virtual reality, apps, and tablets.<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref></sup> As technologies have been
developed and tested, a set of recommended design features has emerged (<xref rid="table1-15459683221146995" ref-type="table">Table 1</xref>). However, the
net effect of optimizing home rehabilitation technology by implementing these
features is still unclear.</p>
              <table-wrap position="float" id="table1-15459683221146995">
                <label>Table 1.</label>
                <caption>
                  <p>Summary of Recommended Design Features for Home Rehabilitation
Technology.</p>
                </caption>
                <alternatives>
                  <graphic xlink:href="10.1177_15459683221146995-table1" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" span="1"/>
                      <col align="char" char="." span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="1" colspan="1">Domain</th>
                        <th align="center" rowspan="1" colspan="1">Recommendation</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td rowspan="6" colspan="1">Hardware design</td>
                        <td rowspan="1" colspan="1">System is small, lightweight, easy to store, portable<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref><xref rid="bibr35-15459683221146995" ref-type="bibr"/><xref rid="bibr36-15459683221146995" ref-type="bibr"/><xref rid="bibr37-15459683221146995" ref-type="bibr"/>-<xref rid="bibr38-15459683221146995" ref-type="bibr">38</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Hardware is adjustable for different body sizes and different
grip types or movements<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Sensors are reliable and validated sensor accuracy<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref><xref rid="bibr35-15459683221146995" ref-type="bibr"/>-<xref rid="bibr36-15459683221146995" ref-type="bibr">36</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System can be interfaced with the user’s existing TV, computer,
or mobile device<sup><xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System is robust and not easily damaged<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr38-15459683221146995" ref-type="bibr">38</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Hardware promotes quality movements and helps prevent
compensatory motions<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="3" colspan="1">Software interface design</td>
                        <td rowspan="1" colspan="1">Software is easy to navigate, with clear and simple operating
instructions<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Software provides a tutorial or introduction to use<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Software contains clear text displayed in a large font
size<sup><xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="2" colspan="1">Operation</td>
                        <td rowspan="1" colspan="1">System requires simple installation, setup, shut down, and
charging procedures<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System is simple enough to be used with minimal external
support<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr38-15459683221146995" ref-type="bibr">38</xref>,<xref rid="bibr40-15459683221146995" ref-type="bibr">40</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="6" colspan="1">Therapeutic activity design</td>
                        <td rowspan="1" colspan="1">Activities are physically challenging but also
achievable<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref>,<xref rid="bibr41-15459683221146995" ref-type="bibr">41</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Activities incorporate games or gamification to enhance
motivation<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Activities are tailored to personal goals, needs, and
interests<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr42-15459683221146995" ref-type="bibr">42</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System includes a variety of activities that accommodate
different ability levels<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Difficulty and duration adapt as user improves, both over time
and in the moment<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr40-15459683221146995" ref-type="bibr">40</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Movements practiced relate to functional movements or activities
of daily living (ADL)<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="8" colspan="1">Performance feedback</td>
                        <td rowspan="1" colspan="1">Feedback is multi-modal (eg, numerical, graphical, and
auditory)<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref>,<xref rid="bibr40-15459683221146995" ref-type="bibr">40</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Feedback on performance is provided during the
activity<sup><xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Summary feedback is presented immediately after the activity is
complete<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref>,<xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">A history of the user’s performance over time is
available<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref>,<xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System enables goal tracking<sup><xref rid="bibr35-15459683221146995" ref-type="bibr">35</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System encourages periods of rest when applicable<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System provides positive feedback with a partial reinforcement
schedule<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">A healthcare professional can monitor the user remotely and
provide feedback<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref>,<xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref>,<xref rid="bibr40-15459683221146995" ref-type="bibr">40</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="4" colspan="1">Support</td>
                        <td rowspan="1" colspan="1">Technical support is available, especially at start of
use<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Support is offered using multiple communication methods (eg,
text, voice, and video)<sup><xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Support is available in different languages<sup><xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System enables healthcare providers to communicate with
user<sup><xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="2" colspan="1">Safety</td>
                        <td rowspan="1" colspan="1">An emergency stop button and/or warning messages are provided
when appropriate<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Hardware design avoids sharp edges, possible finger traps, and
protects the users’ skin<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">Cost</td>
                        <td rowspan="1" colspan="1">System is relatively low cost<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref>,<xref rid="bibr38-15459683221146995" ref-type="bibr">38</xref>,<xref rid="bibr41-15459683221146995" ref-type="bibr">41</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="3" colspan="1">User’s social context</td>
                        <td rowspan="1" colspan="1">System is attractive and acceptable to the user and their family
members<sup><xref rid="bibr33-15459683221146995" ref-type="bibr">33</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System does not create additional burden on family members or
caregivers<sup><xref rid="bibr37-15459683221146995" ref-type="bibr">37</xref></sup></td>
                      </tr>
                      <tr>
                        <td rowspan="1" colspan="1">System can be used cooperatively with a family member or
friend<sup><xref rid="bibr39-15459683221146995" ref-type="bibr">39</xref></sup></td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="table-fn1-15459683221146995">
                    <p>FitMi was designed to incorporate most of these features, except for the
4 that are italicized, which can be grouped into 2 categories: ensuring
that high-quality movements are practiced and facilitating collaboration
with a therapist or caregiver. We generated this table based on a
systematic review of recommendations,<sup><xref rid="bibr34-15459683221146995" ref-type="bibr">34</xref></sup> but also
incorporated suggestions from other studies of home rehabilitation
technology that were not included in that review, as indicated by the
referencing.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p>FitMi (<xref rid="fig1-15459683221146995" ref-type="fig">Figure 1</xref>) is a
commercial home rehabilitation technology designed to put into practice many of
these features (see <xref rid="table1-15459683221146995" ref-type="table">Table
1</xref>). This randomized controlled trial aimed to evaluate the effectiveness
of FitMi in reducing UE impairment compared to conventional paper-based home
exercises in the subacute phase following a stroke. We hypothesized that the
participants in the FitMi group would improve their Upper Extremity Fugl–Meyer
(UEFM) score significantly more than the conventional therapy group, as assessed at
the follow-up assessment.</p>
              <fig position="float" id="fig1-15459683221146995">
                <label>Figure 1.</label>
                <caption>
                  <p>FitMi (produced by Flint Rehab, LLC) consists of 2 force and motion sensing
pucks and a companion “mixed-reality gym” software application. Top row:
FitMi hardware. Bottom row: FitMi software. Note, FitMi can be used with an
individual’s existing computing hardware (Top Right) or with a custom 10″
touchscreen tablet in a kiosk mode that only requires users to turn the
tablet on and touch an icon to access the application (Top Left).</p>
                </caption>
                <graphic xlink:href="10.1177_15459683221146995-fig1" position="float"/>
              </fig>
            </sec>
            <sec sec-type="methods" id="section8-15459683221146995">
              <title>Methods</title>
              <sec id="section9-15459683221146995">
                <title>Device Design</title>
                <p>The FitMi hardware consists of 2 wireless input devices (called pucks), a USB
receiver, a docking station for one-handed charging, and a silicone strap for
users who have difficulty grasping the pucks (see <xref rid="fig1-15459683221146995" ref-type="fig">Figure 1</xref>). Each puck contains an
accelerometer, gyroscope, magnetometer, load cell, onboard LED, and vibration
motor. The top half of the puck is coupled to the bottom half through the load
cell, allowing the device to detect either pressing forces or grip forces. Data
from each puck’s sensor array is wirelessly transmitted to the USB receiver,
which can be plugged into any computer and used without configuring the devices.
Using this data and custom software algorithms, FitMi detects the completion of
40 different exercises for the hands, arms, trunk, and legs that were designed
with the input of experienced stroke therapists (<ext-link xlink:href="https://journals.sagepub.com/doi/suppl/10.1177/15459683221146995" ext-link-type="uri">Supplemental Text 1</ext-link>). For each exercise, the FitMi software
presents users with a repetition goal for a bout of exercise, progress toward
that goal, and real-time feedback each time a repetition is completed. Before
exercising, users are shown written instructions and images of the starting and
ending position for each repetition of the given exercise. They can also watch a
video of an experienced therapist demonstrating the exercise and providing tips
to prevent compensatory movement patterns. Once users begin an exercise, the
screen indicates the exercise position they need to move toward (<xref rid="fig1-15459683221146995" ref-type="fig">Figure 1</xref>), and the system
provides a game-like environment with music that encourages movement intensity.
Users are provided with audio, visual, and haptic feedback as they repetitively
move between the starting and ending positions for each exercise. The height of
an exercise intensity bar indicates their exercise rate, and if the rate slows
too much, the bar hits a “bomb,” and the exercise session ends. After an
exercise is completed, the software displays the user’s performance history over
time, both within an exercise session and across days of use. To optimize the
system’s challenge level, the software progressively unlocks new exercises and
adapts the goal number of repetitions for each exercise based on the user’s past
performance. At any time, users can access an interactive tutorial on how to use
the software. The FitMi software can run on a personal computer or a custom 10″
touchscreen tablet in a kiosk mode (ie, the tablet runs no other software
besides the FitMi software).</p>
              </sec>
              <sec id="section10-15459683221146995">
                <title>Trial Design</title>
                <p>This study was a single-site, single-blind randomized controlled trial comparing
home-based therapy with FitMi to conventional therapy for individuals in the
subacute phase of stroke. The study was performed at Rancho Los Amigos National
Rehabilitation Center in Downey, CA. Participants were invited for an initial
assessment to confirm they met the inclusion criteria and to establish baseline
measures. Participants provided informed written consent. Qualifying
participants were randomly assigned to either the FitMi group or the
conventional group. Participants in both groups were instructed to perform
self-guided therapy for at least 3 hours/week for 3 consecutive weeks. All
participants received weekly phone calls from a supervising therapist. After the
3-week exercise period, participants returned for an end-of-therapy assessment
and to return study materials. Participants returned 1 month later for a
follow-up assessment. The trial was pre-registered on ClinicalTrials.gov
(NCT03503617) and approved by the Rancho Research Institute, Inc. Institutional
Review Board at Rancho Los Amigos National Rehabilitation Center (IRB #263).</p>
              </sec>
              <sec id="section11-15459683221146995">
                <title>Participants</title>
                <p>Inclusion criteria were: experienced one or more strokes between 2 weeks and
4 months prior; baseline UEFM Score &gt;5 and ≤55 out of 66; absence of moderate
to severe pain defined as a score of 4 or lower on the 10-point visual-analog
pain scale; ability to understand the instructions to operate FitMi; and aged 18
to 85 years old, to limit potential confounds due to naturally diminished
physical mobility and cognitive function associated with older age.<sup><xref rid="bibr43-15459683221146995" ref-type="bibr">43</xref></sup> Exclusion
criteria were: concurrent severe medical problems that precluded the individual
from participating in routine rehabilitation; visual deficits defined as a score
&gt;1 on question 3 of the NIH Stroke Scale (NIHSS); severe cognitive deficits
or apraxia defined as a score &gt;0 on questions 1a and 1c of the NIHSS; severe
neglect defined as a score &gt;1 on question 11 of the NIHSS; severe aphasia
defined as a score &gt;1 on question 9 of the NIHSS; and enrollment in other
therapy studies. Recruitment aimed to balance the age, ethnicity, and gender of
the study participants to be representative of Los Angeles County in California,
USA. All participants provided informed consent.</p>
                <p>Using an estimated Cohen’s <italic toggle="yes">d</italic><sup><xref rid="bibr44-15459683221146995" ref-type="bibr">44</xref></sup> effect size of 1.05 based
on long-term follow-up data from a previous arm training study during subacute
stroke,<sup><xref rid="bibr45-15459683221146995" ref-type="bibr">45</xref></sup> power analysis established that 21 participants in each
group would provide a 90% chance of detecting a significant difference between
FitMi and conventional therapy at the .05 significance level (two-tailed
<italic toggle="yes">t</italic>-test). To account for 20% dropout, the target sample size
was n = 25 participants in each group.</p>
                <p>Adaptive randomization was used to ensure matched levels of impairment between
the FitMi and conventional therapy groups. Specifically, subjects were
stratified by their UEFM Score into 3 levels (ie, 5-22, 23-39, 40-55) and then
randomized by alternating block allocation.<sup><xref rid="bibr46-15459683221146995" ref-type="bibr">46</xref></sup></p>
              </sec>
              <sec id="section12-15459683221146995">
                <title>Intervention</title>
                <p>Participants randomized to the FitMi group were given a FitMi system with a
custom 10″ touchscreen tablet. They received 30 minutes of training on how to
set up and use the FitMi system. They were instructed to spend most of their
time performing UE exercises, but access to the trunk and leg exercises in the
FitMi software was not disabled. Participants randomized to the conventional
therapy group were given a booklet of paper exercises that were selected from
the same library of 40 exercises available in the FitMi software. The booklet
was placed in a sensorized folder which included an accelerometer to detect
movement events and a magnetometer and magnet on opposite sleeves to detect when
the folder was opened or closed. These events were recorded to a memory card by
an embedded microcontroller.</p>
                <p>For both groups, a supervising rehabilitation therapist selected the exercises
for each participant based on their specific impairments. All participants
received 30 minutes of training from the therapist on how to perform the
selected exercises correctly. After the 3-week exercise period, participants
returned for an end-of-therapy assessment. At this assessment, participants
returned the FitMi system or the sensorized booklet of exercises for data
collection. Participants returned 1 month later for a follow-up assessment.</p>
              </sec>
              <sec id="section13-15459683221146995">
                <title>Outcomes</title>
                <p>The primary outcome measure was the change in UEFM score<sup><xref rid="bibr47-15459683221146995" ref-type="bibr">47</xref></sup> from
baseline assessment to follow-up. UEFM was assessed at baseline, end-of-therapy,
and follow-up. Secondary measures included the Box and Blocks Test,<sup><xref rid="bibr48-15459683221146995" ref-type="bibr">48</xref></sup> the
10 Meter Walk Test,<sup><xref rid="bibr49-15459683221146995" ref-type="bibr">49</xref></sup> the Modified Ashworth Spasticity (MAS) scale<sup><xref rid="bibr50-15459683221146995" ref-type="bibr">50</xref></sup> for the
elbow, wrist, and fingers, and the Visual Analog Pain (VAP) scale for the UE,
all of which were assessed at baseline, end-of-therapy, and follow-up. Motor
Activity Log (MAL) was measured at end-of-therapy and follow-up to assess
self-reported quantity and quality of movement.<sup><xref rid="bibr51-15459683221146995" ref-type="bibr">51</xref></sup> The European Quality of
Life five dimensions, three levels (EQ-5D-3L) and its companion Visual Analog
Scale (EQ-VAS) were measured at end-of-therapy and at follow-up to assess
overall perceived health state,<sup><xref rid="bibr52-15459683221146995" ref-type="bibr">52</xref>,<xref rid="bibr53-15459683221146995" ref-type="bibr">53</xref></sup> and the Intrinsic
Motivation Inventory (IMI)<sup><xref rid="bibr54-15459683221146995" ref-type="bibr">54</xref></sup> categories of
Interest/Enjoyment, Value/Usefulness, and Effort/Importance were measured at
end-of-therapy to assess participants’ perceived motivation. These measures are
widely used in stroke rehabilitation research and have good sensitivity and
reliability. All assessments were performed by a blinded, trained evaluator.</p>
                <p>To assess adherence, the FitMi software recorded the date, time, and number of
repetitions completed for each exercise, and the sensorized folder used in the
conventional therapy measured the times at which the participants opened the
booklet.</p>
              </sec>
              <sec id="section14-15459683221146995">
                <title>Statistical Methods</title>
                <p>Statistical analyses were performed using Matlab R2020 software. For measures
taken at baseline and follow-up, the change from baseline to follow-up was
calculated. Then the changes were compared between groups using an unpaired
two-tailed <italic toggle="yes">t</italic>-test. This was the analysis specified for the
primary outcome in the statistical analysis protocol established before the
project started. For the UEFM, we also assessed within-group changes between
timepoints using paired <italic toggle="yes">t</italic>-tests. We corrected for multiple
comparisons for secondary outcomes using a Holm-Bonferroni correction. Cohen’s
<italic toggle="yes">d</italic>, using pooled standard deviation, was used to assess the
effect size of the difference in changes between groups. As a post-hoc,
supplemental analysis, mixed model ANOVAs were used to analyze outcomes taken at
all 3 time points, using the mixed procedure in SPSS 28.0, to further account
for variance over time. If a significant time and group interaction was found,
pairwise comparisons were then used to find differences within or between groups
at any time point by using Sidak adjustments to correct for multiple
comparisons.</p>
                <p>MAS scores were grouped by flexion or extension items and summed to obtain lumped
MAS extension and flexion values. We quantified items marked with a “+,” with an
additional 0.5 points for calculations. EQ-5D-L3 was analyzed
following.<sup><xref rid="bibr52-15459683221146995" ref-type="bibr">52</xref>,<xref rid="bibr53-15459683221146995" ref-type="bibr">53</xref></sup> Responses to questions in IMI categories were averaged
within the category for each participant and compared across groups using
Wilcoxon rank sum tests.</p>
                <p>Several participants dropped out of the study (see <xref rid="fig2-15459683221146995" ref-type="fig">Figure 2</xref>). Subjects who did not return
for an end-of-therapy assessment were not considered for analysis. Missing data
was imputed to keep the same number of participants across timepoints for
analysis using the MissForest random forest imputation algorithm.<sup><xref rid="bibr55-15459683221146995" ref-type="bibr">55</xref></sup></p>
                <fig position="float" id="fig2-15459683221146995">
                  <label>Figure 2.</label>
                  <caption>
                    <p>Participant flow diagram. Subjects who did not return for an
end-of-therapy assessment were not considered for analysis. Missing data
was imputed as described in the statistical methods to maintain group
sizes across all analyses.</p>
                  </caption>
                  <graphic xlink:href="10.1177_15459683221146995-fig2" position="float"/>
                </fig>
                <p>To assess the ability of FitMi to motivate an appropriately high dose of home
therapy, we performed a post-hoc exploratory analysis comparing the total number
of repetitions that FitMi participants completed to a theoretical target dose of
2700 repetitions. A dose of 2700 repetitions of UE exercise corresponds to
300 repetitions/hour (5 reps/minute) over 9 hours of exercise, an intensity and
duration sufficient to provoke a forelimb rehabilitative effect in a rodent
model of stroke.<sup><xref rid="bibr56-15459683221146995" ref-type="bibr">56</xref></sup></p>
              </sec>
              <sec id="section15-15459683221146995">
                <title>Interim Analysis</title>
                <p>Due to the unexpected additional risks to participating in this study due to the
COVID-19 pandemic, an unplanned interim futility/efficacy analysis of the
primary outcome measure was conducted after recruitment was halted in March
2020. Group labels were removed, and the analysis was reviewed by an independent
investigator. For the futility analysis, a conditional power of 20% was
selected. For the efficacy analysis, a <italic toggle="yes">P</italic>-value of .033 was
selected using the Lan-DeMets alpha spending function for the Pocock boundary
(n = 27 out of a planned 50 at interim analysis).<sup><xref rid="bibr57-15459683221146995" ref-type="bibr">57</xref></sup></p>
              </sec>
            </sec>
            <sec sec-type="results" id="section16-15459683221146995">
              <title>Results</title>
              <sec id="section17-15459683221146995">
                <title>Recruitment and Participant Flow</title>
                <p>Participants were recruited from November 20, 2018, until March 12, 2020, when
the study was halted due to the COVID-19 pandemic. In the interim analysis, a
significant difference in the primary outcome measure was observed between
groups (two-tailed <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> &lt; .033). Thus,
recruitment was halted early based on detected efficacy at 27 out of a planned
50 participants.</p>
                <p>Participant enrollment and allocation details are shown following CONSORT
guidelines in <xref rid="fig2-15459683221146995" ref-type="fig">Figure 2</xref>.
Out of 300 individuals screened for eligibility, 27 were randomized (<xref rid="table2-15459683221146995" ref-type="table">Table 2</xref>). Two
participants from the conventional therapy group did not complete the
end-of-therapy or follow-up assessment due to a second stroke for one and
COVID-19 restrictions for the other. An additional conventional therapy
participant could not return for the follow-up due to COVID-19 restrictions.</p>
                <table-wrap position="float" id="table2-15459683221146995">
                  <label>Table 2.</label>
                  <caption>
                    <p>Demographics of Recruited Participants at Baseline Aggregated by
Group.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15459683221146995-table2" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">Control</th>
                          <th align="center" rowspan="1" colspan="1">FitMi</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td rowspan="1" colspan="1">Number of participants</td>
                          <td rowspan="1" colspan="1">13</td>
                          <td rowspan="1" colspan="1">14</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Age (y)</td>
                          <td rowspan="1" colspan="1">52 ± 8.7</td>
                          <td rowspan="1" colspan="1">50.3 ± 10.9</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Sex (M/F)</td>
                          <td rowspan="1" colspan="1">9/4</td>
                          <td rowspan="1" colspan="1">14/0</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Ethnicity (H/N)</td>
                          <td rowspan="1" colspan="1">10 H, 3 N</td>
                          <td rowspan="1" colspan="1">8 H, 6 N</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Stroke type (I, H, B)</td>
                          <td rowspan="1" colspan="1">9 I, 3 H, 1 B</td>
                          <td rowspan="1" colspan="1">11 I, 3 H</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Impaired side (L/R)</td>
                          <td rowspan="1" colspan="1">8 L, 5 R</td>
                          <td rowspan="1" colspan="1">10 L, 4 R</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Number dominant side impaired</td>
                          <td rowspan="1" colspan="1">5</td>
                          <td rowspan="1" colspan="1">4</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1">Weeks post stroke</td>
                          <td rowspan="1" colspan="1">10.1 ± 5.1, [4.6, 17.6]</td>
                          <td rowspan="1" colspan="1">9.7 ± 4.5, [4.3, 17.9]</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn2-15459683221146995">
                      <p>Abbreviations: H, Hispanic/Latino; N, not Hispanic/Latino; I,
ischemic; H, hemorrhagic; B, both ischemic and hemorrhagic.</p>
                    </fn>
                    <fn id="table-fn3-15459683221146995">
                      <p>Where applicable, values are reported as Mean ± SD, [minimum,
maximum]. Weeks Post Stroke indicates the number of weeks between
the participant’s stroke and the date of their baseline
evaluation.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="section18-15459683221146995">
                <title>Efficacy</title>
                <p>All measures recorded at baseline, end-of-therapy, and follow-up assessments are
reported in <xref rid="table3-15459683221146995" ref-type="table">Table
3</xref>. All measures not recorded at baseline but recorded at end-of-therapy
and follow-up are reported at the bottom of <xref rid="table3-15459683221146995" ref-type="table">Table 3</xref>. UEFM scores at baseline
ranged from 12 to 53 for the FitMi group and 9 to 50 for the conventional
therapy group, indicating enrollment across a broad range of motor impairments
(<ext-link xlink:href="https://journals.sagepub.com/doi/suppl/10.1177/15459683221146995" ext-link-type="uri">Supplemental Figure 1</ext-link>). There was no significant difference in
the UEFM score, or any other outcomes, between groups at baseline
(<italic toggle="yes">P</italic> &gt; .3).</p>
                <table-wrap position="float" id="table3-15459683221146995">
                  <label>Table 3.</label>
                  <caption>
                    <p>Results for Outcome Measures for FitMi and Conventional Therapy
Groups.</p>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="10.1177_15459683221146995-table3" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                        <col align="char" char="." span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th rowspan="1" colspan="1"/>
                          <th align="center" rowspan="1" colspan="1">BL</th>
                          <th align="center" rowspan="1" colspan="1">EOT</th>
                          <th align="center" rowspan="1" colspan="1">FU</th>
                          <th align="center" rowspan="1" colspan="1">Δ from BL to FU</th>
                          <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value between-group
comparisons of Δ</th>
                          <th align="center" rowspan="1" colspan="1">Effect size</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td colspan="7" rowspan="1">UEFM</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">36.7 ± 15.4</td>
                          <td rowspan="1" colspan="1">43.2 ± 16.3</td>
                          <td rowspan="1" colspan="1">44.7 ± 16.2</td>
                          <td rowspan="1" colspan="1">8.0 ± 4.6</td>
                          <td rowspan="2" colspan="1">.029<sup><xref rid="table-fn6-15459683221146995" ref-type="table-fn">a</xref></sup></td>
                          <td rowspan="2" colspan="1">0.925</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">35.18 ± 14.5</td>
                          <td rowspan="1" colspan="1">36.64 ± 14.8</td>
                          <td rowspan="1" colspan="1">38.18 ± 16.2</td>
                          <td rowspan="1" colspan="1">3.0 ± 6.1</td>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">Box and blocks</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">25.4 ± 17.6</td>
                          <td rowspan="1" colspan="1">28.9 ± 17.6</td>
                          <td rowspan="1" colspan="1">30.2 ± 19.7</td>
                          <td rowspan="1" colspan="1">4.8 ± 6.3</td>
                          <td rowspan="2" colspan="1">.701</td>
                          <td rowspan="2" colspan="1">0.156</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">23.5 ± 14.8</td>
                          <td rowspan="1" colspan="1">24.5 ± 15.8</td>
                          <td rowspan="1" colspan="1">27.2 ± 16.1</td>
                          <td rowspan="1" colspan="1">3.7 ± 7.2</td>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">10 meter walk test (m/s)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">0.98 ± 0.37</td>
                          <td rowspan="1" colspan="1">1.02 ± 0.40</td>
                          <td rowspan="1" colspan="1">1.06 ± 0.41</td>
                          <td rowspan="1" colspan="1">0.08±0.020</td>
                          <td rowspan="2" colspan="1">.857</td>
                          <td rowspan="2" colspan="1">0.071</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">0.86 ± 0.28</td>
                          <td rowspan="1" colspan="1">0.87 ± 0.40</td>
                          <td rowspan="1" colspan="1">0.92 ± 0.48</td>
                          <td rowspan="1" colspan="1">0.06 ± 0.33</td>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">MAS (extension)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">0.57 ± 0.87</td>
                          <td rowspan="1" colspan="1">0.50 ± 0.71</td>
                          <td rowspan="1" colspan="1">0.46 ± 0.69</td>
                          <td rowspan="1" colspan="1">−0.11 ± 0.59</td>
                          <td rowspan="2" colspan="1">.944</td>
                          <td rowspan="2" colspan="1">0.029</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">0.55 ± 1.04</td>
                          <td rowspan="1" colspan="1">0.18 ± 0.40</td>
                          <td rowspan="1" colspan="1">0.45 ± 0.82</td>
                          <td rowspan="1" colspan="1">−0.09 ± 0.54</td>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">MAS (flexion)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">2.8 ± 1.9</td>
                          <td rowspan="1" colspan="1">2.4 ± 2.2</td>
                          <td rowspan="1" colspan="1">2.5 ± 2.0</td>
                          <td rowspan="1" colspan="1">−0.29 ± 1.59</td>
                          <td rowspan="2" colspan="1">.828</td>
                          <td rowspan="2" colspan="1">0.091</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">2.4 ± 2.1</td>
                          <td rowspan="1" colspan="1">1.6 ± 1.5</td>
                          <td rowspan="1" colspan="1">2.0 ± 2.2</td>
                          <td rowspan="1" colspan="1">−0.41 ± 1.10</td>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">VAP</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1">1.3 ± 1.7</td>
                          <td rowspan="1" colspan="1">2.1 ± 2.4</td>
                          <td rowspan="1" colspan="1">2.6 ± 2.1</td>
                          <td rowspan="1" colspan="1">1.4 ± 2.3</td>
                          <td rowspan="2" colspan="1">.176</td>
                          <td rowspan="2" colspan="1">0.555</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1">1.5 ± 1.5</td>
                          <td rowspan="1" colspan="1">4.0 ± 3.4</td>
                          <td rowspan="1" colspan="1">4.3 ± 2.8</td>
                          <td rowspan="1" colspan="1">2.8 ± 2.9</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">EOT</td>
                          <td rowspan="1" colspan="1">FU</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">MAL (AS)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2.81 ± 0.74</td>
                          <td rowspan="1" colspan="1">3.11 ± 1.14</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2.52 ± 1.74</td>
                          <td rowspan="1" colspan="1">2.41 ± 1.82</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">MAL (HW)</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2.78 ± 1.01</td>
                          <td rowspan="1" colspan="1">3.01 ± 1.26</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">2.22 ± 1.58</td>
                          <td rowspan="1" colspan="1">2.26 ± 1.71</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">EQ-5D-3L</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">0.77 ± 0.10</td>
                          <td rowspan="1" colspan="1">0.74 ± 0.06</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">0.84 ± 0.09</td>
                          <td rowspan="1" colspan="1">0.82 ± 0.11</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td colspan="7" rowspan="1">EQ-VAS</td>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> FitMi therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">63.93 ± 17.24</td>
                          <td rowspan="1" colspan="1">74.2 ± 15.6</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td rowspan="1" colspan="1"> Conventional therapy</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1">71.36 ± 14.16</td>
                          <td rowspan="1" colspan="1">70.27 ± 10.90</td>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                          <td rowspan="1" colspan="1"/>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="table-fn4-15459683221146995">
                      <p>Abbreviations: BL, baseline; EOT, end-of-therapy; FU, follow-up;
UEFM, Upper Extremity Fugl–Meyer; MAS, Modified Ashworth scale for
spasticity; VAP, visual analog pain; MAL, motor activity log;
EQ-5D-3L, European Quality of Life five dimensions, three levels;
EQ-VAS, EuroQol Visual Analog Scale.</p>
                    </fn>
                    <fn id="table-fn5-15459683221146995">
                      <p>For measures with a baseline assessment, the change from baseline to
follow-up was calculated. For each measure, the change was compared
between groups using unpaired, two-tailed <italic toggle="yes">t</italic>-tests.
<italic toggle="yes">T</italic>-tests for secondary outcomes were corrected
for multiple comparisons using a Holm-Bonferroni correction. The
difference between groups was quantified using Cohen’s d effect
size. The absolute value of the effect size is shown here.</p>
                    </fn>
                    <fn id="table-fn6-15459683221146995">
                      <label>a</label>
                      <p>Indicates a significant difference using the corrected α-value for
that assessment.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>For the primary outcome measure, the average change in UEFM from baseline to
follow-up for participants in the FitMi group (n = 14) was 8.0 ± 4.6 compared to
an average change of 3.0 ± 6.1 for participants in the conventional therapy
group (n = 11), a significant difference with a large effect size
(<italic toggle="yes">P</italic> = .029, <italic toggle="yes">d</italic> = 0.925; <xref rid="table3-15459683221146995" ref-type="table">Table 3</xref>). A
significant within-group increase in UEFM score was found for the FitMi group
when comparing baseline to end-of-therapy and follow-up
(<italic toggle="yes">P</italic> &lt; .001 for both intervals), but not for the conventional
therapy group at either assessment (<xref rid="fig3-15459683221146995" ref-type="fig">Figure 3</xref>).</p>
                <fig position="float" id="fig3-15459683221146995">
                  <label>Figure 3.</label>
                  <caption>
                    <p>(A) Average change in Upper Extremity Fugl–Meyer (UEFM) score for FitMi
group and conventional therapy group at each assessment. The error bars
represent 1 SD. (BL = Baseline) FitMi participants improved
significantly more than the conventional therapy group. *Indicates a
significant within-group difference between UEFM scores at each time
point compared to baseline (<italic toggle="yes">p</italic> &lt; .01). **Indicates a
significant difference between the change in UEFM between groups at each
time point (<italic toggle="yes">p</italic> &lt; .033). (B) FitMi participants’ total
number of repetitions plotted as a function of their baseline UEFM
score. The horizontal dashed line indicates a theoretical target dose of
2700 repetitions. Note, there are 2 overlapping participants at baseline
UEFM score 53, one who exceeded the threshold and one who did not. (C)
FitMi participants’ average repetition rate, in repetitions per minute,
plotted as a function of their baseline UEFM score.</p>
                    <p>Abbreviations: EOT, end-of-therapy; FU, follow-up.</p>
                  </caption>
                  <graphic xlink:href="10.1177_15459683221146995-fig3" position="float"/>
                </fig>
                <p>The 2 groups’ scores did not change significantly differently for any of the
secondary outcomes.</p>
                <p>Mixed model ANOVA analysis for UFEM scores found a significant time effect
(<italic toggle="yes">F</italic>(1.771, 40.725) = 21.119, <italic toggle="yes">P</italic> &lt; .001,
ηp<sup>2</sup> = .479), and a significant time × group interaction
(<italic toggle="yes">F</italic>(1.771, 40.725) = 5.506, <italic toggle="yes">P</italic> = .010,
ηp<sup>2</sup> = .193), but not a significant group effect. Pairwise
comparisons show the FitMi group’s UEFM scores increased significantly between
baseline and end-of-therapy (<italic toggle="yes">P</italic> &lt; .001), and between baseline
and follow-up (<italic toggle="yes">P</italic> &lt; .001) but did not significantly change
between end-of-therapy and follow-up. Significant time effects were found for
the Box and Blocks assessment (<italic toggle="yes">F</italic>(1.718, 39.511) = 7.376,
<italic toggle="yes">P</italic> &lt; .002, ηp<sup>2</sup> = .243) and the VAP
(<italic toggle="yes">F</italic>(2, 46) = 9.175, <italic toggle="yes">P</italic> &lt; .001,
ηp<sup>2</sup> = .285), but neither of these assessments showed significant
time × group interactions or group effects. No significant effects were found
for the 10 m walk test, MAS Extension, or MAS Flexion. Sphericity was violated
for the UEFM and Box and Blocks scores, so the Huynh-Feldt corrected results are
reported for these assessments.</p>
              </sec>
              <sec id="section19-15459683221146995">
                <title>Safety and Motivation</title>
                <p>No significant harms related to the study were reported or observed over the
course of the study. For participants in the FitMi therapy group, no significant
change was found between baseline and end-of-therapy for MAS or VAP scores
(paired <italic toggle="yes">t</italic>-test <italic toggle="yes">P</italic> &gt; .05). No significant
difference was found between the FitMi therapy and conventional therapy
participants in their responses to IMI questions related to Interest/Enjoyment
(FitMi 5.1 ± 1.1, Conventional 5.4 ± 1.1), Value/Usefulness (FitMi 6.5 ± 0.7,
Conventional 6.3 ± 0.6), and Effort/Importance (FitMi 6.4 ± 1.5, Conventional
6.7 ± 0.6). All items are rated on a scale from 0 to 7.</p>
                <p>Participants interacted with the FitMi software for a median of 47% of the
21 days of the intervention period (range = 23%-100%). FitMi participants
interacted with the system for 5.4 ± 4.1 hours. Only 2 participants completed or
exceeded the recommended 9 hours of interaction time. Due to technical issues
with battery life, only 4 out of 13 sensorized folders provided to participants
in the conventional therapy group were returned with recoverable data. These 4
participants interacted with their folders for 41%, 73%, 45%, and 100% of the
21 days of the intervention.</p>
                <p>Of the 14 participants in the FitMi group, 9 out of 14 (64%) completed the
theoretical target dose of at least 2700 repetitions (as defined in the Methods)
over 3 weeks of exercise, with 7 participants completing more than 3 times this
amount (<xref rid="fig3-15459683221146995" ref-type="fig">Figure 3B</xref>).
Across the 4 exercise categories available in the FitMi software (hand, arm,
trunk, and leg exercises), the participants completed 4051 ± 4986 [130, 18 617],
2744 ± 3076 [186, 11 262], 1550 ± 1439 [176, 5469], 1813 ± 2029 [0, 6908]
repetitions, respectively (reported as mean ± standard deviation [minimum,
maximum]).</p>
                <p>We tested whether less impaired participants achieved more repetitions with
FitMi. To do this, we ranked participants by baseline UEFM score and then split
them into evenly sized groups (n = 7) thus creating lower and higher UEFM groups
defined by a UEFM cutoff of 40. Comparing total repetitions between groups
(4427 ± 3648 [832, 8694] vs 15 890 ± 13 412 [2565, 42 256], respectively)
revealed a significantly greater amount of exercise in the higher UEFM group
(unpaired <italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> = .0497). In terms of
exercise rate, the lower UEFM group exercised more slowly (26 ± 8 reps/minute)
than the higher UEFM group (55 ± 6 reps/minute) (unpaired
<italic toggle="yes">t</italic>-test, <italic toggle="yes">P</italic> &lt; .001) (<xref rid="fig3-15459683221146995" ref-type="fig">Figure 3C</xref>). The change in UEFM score
from baseline to end-of-therapy was moderately correlated with the total number
of arm and hand repetitions each participant achieved
(<italic toggle="yes">P</italic> = .005, <italic toggle="yes">r</italic><sup>2</sup> = .52, <ext-link xlink:href="https://journals.sagepub.com/doi/suppl/10.1177/15459683221146995" ext-link-type="uri">Supplemental Figure 2</ext-link>); the correlation was not significant at
follow-up (<italic toggle="yes">P</italic> = .11, <italic toggle="yes">r</italic><sup>2</sup> = .22,
<ext-link xlink:href="https://journals.sagepub.com/doi/suppl/10.1177/15459683221146995" ext-link-type="uri">Supplemental Figure 3</ext-link>). The participant with the highest number
of repetitions was omitted as an outlier for these correlation analyses.</p>
              </sec>
            </sec>
            <sec sec-type="discussion" id="section20-15459683221146995">
              <title>Discussion</title>
              <p>We compared the effectiveness of a sensorized exercise system, FitMi, with a
conventional exercise program specified using a paper booklet for at-home movement
training in subacute stroke. Participants who exercised with FitMi improved
significantly more on the primary outcome, the change in the UEFM scale from
baseline to follow-up, compared to the participants in the conventional therapy
group without increasing UE spasticity or pain. We first discuss the significance of
these results, followed by limitations and directions for future research.</p>
              <sec id="section21-15459683221146995">
                <title>Toward Optimizing Home Rehabilitation Technology</title>
                <p>As reviewed in <xref rid="table1-15459683221146995" ref-type="table">Table
1</xref>, FitMi was designed in a way consistent with previous research that
recommended desirable features for home rehabilitation technology. The current
study provides evidence that these features, when bundled together, make home
movement training more effective at reducing UE impairment compared to the
conventional, paper-based prescription of exercise in subacute stroke. Although
the core mechanisms remain unclear, we speculate that this result relates to 2
causes. We hypothesize that the FitMi participants achieved more movement
repetitions than the conventional therapy group because FitMi participants
likely exercised at a higher intensity. Specifically, the FitMi technology
encouraged rapid repetition of exercise and adaptively progressed the goal
number of repetitions for each exercise based on each user’s past
performance—something that paper exercises cannot do. Indeed, the average
exercise rates were quite high compared to what might be expected with
paper-based exercise, being 26 reps/minute for the lower UEFM group and
55 reps/minute for the higher UEFM group. Interestingly, the IMI scores did not
indicate that subjective self-report of motivation was significantly higher for
the FitMi group. This may be because both groups had high motivation to achieve
recovery at this early stage regardless of intervention type. Future studies
could focus on understanding the motivation to recover versus the motivation to
exercise at a high intensity.</p>
                <p>An important question is whether the system was usable by more severely impaired
individuals, as there are fewer options available for such persons for
continuing movement practice. The lower half of participants with more severe
impairments (UEFM &lt;40) still achieved on average 4427 repetitions, an amount
that exceeded the theoretical target dose of 2700 repetitions. Notably, most
participants were able to exceed the 2700-repetition target in a shorter amount
of time than was prescribed, because they achieved an average rate of exercise
of 41 ± 17 reps/minutes, which was greater than the 5 reps/minute we estimated a
priori. This indicates that FitMi was accessible and motivating for individuals
with a range of impairment levels, which is a key requirement for optimizing
home rehabilitation technology as it allows a single solution to be used across
a broad population.</p>
                <p>As shown in <xref rid="table1-15459683221146995" ref-type="table">Table 1</xref>,
FitMi does not currently incorporate design features to (1) ensure that only
high-quality movements can be practiced, or (2) facilitate collaboration with a
therapist or caregiver. A key reason these features were previously recommended
was to ensure that patients do not practice unsafe or compensatory movement
patterns during unsupervised at-home therapy. However, in the present study, we
found no significant increase in spasticity or pain in the FitMi group. Further,
the observed reduction in UE impairment in the FitMi group cannot be explained
by the learning of compensatory movements, since compensatory movements are
discounted in the UEFM scoring process. Thus, foregoing these features in
FitMi’s design did not appear to reduce safety or encourage abnormal movement
execution in the present study. Nonetheless, incorporating these features into
FitMi’s design might improve future results.</p>
                <p>While home training with FitMi led to a significantly greater reduction in UE
impairment than paper-based exercise, an important question is whether the
amount of improvement was clinically significant. The Minimal Clinically
Important Difference (MCID) for the UEFM has been reported to be 4 points for
subacute patients,<sup><xref rid="bibr58-15459683221146995" ref-type="bibr">58</xref></sup> although another study with younger patients (average
age 52) closer to the mean age of the participants in our study estimated it to
be 9 points in the first few weeks (4-24 weeks) after stroke.<sup><xref rid="bibr59-15459683221146995" ref-type="bibr">59</xref></sup> The MCID
was reported to be ~5 points in the chronic stage of stroke for older
patients.<sup><xref rid="bibr60-15459683221146995" ref-type="bibr">60</xref></sup> Six out of 14 (43%) of participants in the FitMi group
achieved a 9-point change in UEFM (with 2 additional participants achieving
8-point changes) compared to 2 out of 10 (20%) of participants in the
conventional therapy group (with none achieving 8-point changes). Thus, exercise
with FitMi appears to have a clinically meaningful impact for more individuals
than paper-based exercise.</p>
              </sec>
              <sec id="section22-15459683221146995">
                <title>Limitations and Future Directions</title>
                <p>No female participants were recruited into the FitMi therapy group, which limits
the generalizability of the reported results. A smaller percentage of FitMi
participants were impaired on their dominant side than in the conventional group
(29% vs 38%). Alternating allocation has been shown to be prone to selection
bias<sup><xref rid="bibr61-15459683221146995" ref-type="bibr">61</xref></sup> and does not allow for naïve allocation. The randomization
procedure used was peer-reviewed and approved before the study began, and
analysis of group characteristics at baseline did not reveal any statistically
significant differences between group characteristics. However, future protocols
could be improved by using different randomization methods. While the FitMi and
conventional therapy group’s clinical assessment scores were matched at
baseline, we did not evaluate possible differences in their potential for
recovery using biomarkers such as motor-evoked potentials.<sup><xref rid="bibr62-15459683221146995" ref-type="bibr">62</xref>,<xref rid="bibr63-15459683221146995" ref-type="bibr">63</xref></sup>
Recruitment was also stopped early due to the COVID-19 pandemic, reducing
statistical power. Several participants who were recruited dropped out of the
study (most due to COVID-19 restrictions, and all from the conventional therapy
group) and required multiple imputation for analysis. Finally, while the number
of days participants in the FitMi group exercised had a similar distribution to
the 4 participants in the conventional therapy group for whom we collected data
from their sensorized folders, we did not quantify the number of exercise
repetitions participants in the conventional therapy group achieved. This limits
our ability to determine if the observed benefits of FitMi are simply due to a
higher number of movements performed or a specific benefit of the FitMi
device.</p>
                <p>Future research could study how exercise technologies such as FitMi can best be
integrated into routine clinical practice. Providing stroke survivors with FitMi
in any waiting period between the end of their inpatient treatment and the start
of their outpatient treatment, or after they have used all the outpatient
therapy visits allotted by their health insurance, could improve outcomes. We
recently studied the use of the FitMi sensors in conjunction with an
activity-management app to assist in home rehabilitation.<sup><xref rid="bibr64-15459683221146995" ref-type="bibr">64</xref></sup>
Therapists reported that remote monitoring and the use of a physical movement
sensor were motivating to their patients and increased adherence. We also
recently studied the long-term, self-determined exercise patterns of a large
number of individuals (N = 2581) who engaged in home rehabilitation with FitMi.
We found that an optimized challenge level and regular initiation of exercise
sessions predicted the achievement of a greater amount of overall rehabilitation
exercise.<sup><xref rid="bibr65-15459683221146995" ref-type="bibr">65</xref></sup> Going forward, the fine-grained data collection
facilitated by an accessible, commercially available, sensorized home exercise
system such as FitMi opens interesting avenues of analysis to investigate the
effects of the amount and type of exercise on rehabilitation outcomes in the
real world.</p>
              </sec>
            </sec>
            <sec sec-type="supplementary-material" id="section23-15459683221146995" specific-use="figshare">
              <title>Supplemental Material</title>
              <supplementary-material id="suppl1-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-doc-5-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-doc-5-nnr-10.1177_15459683221146995.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-doc-5-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
              <supplementary-material id="suppl2-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-pdf-4-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-pdf-4-nnr-10.1177_15459683221146995.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-pdf-4-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
              <supplementary-material id="suppl3-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-pdf-6-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-pdf-6-nnr-10.1177_15459683221146995.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-pdf-6-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
              <supplementary-material id="suppl4-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-tif-1-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-tif-1-nnr-10.1177_15459683221146995.tif">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-tif-1-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
              <supplementary-material id="suppl5-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-tiff-2-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-tiff-2-nnr-10.1177_15459683221146995.tiff">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-tiff-2-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
              <supplementary-material id="suppl6-15459683221146995" position="float" content-type="local-data">
                <caption>
                  <title>sj-tiff-3-nnr-10.1177_15459683221146995 – Supplemental material for
Optimized Home Rehabilitation Technology Reduces Upper Extremity Impairment
Compared to a Conventional Home Exercise Program: A Randomized, Controlled,
Single-Blind Trial in Subacute Stroke</title>
                </caption>
                <media xlink:href="sj-tiff-3-nnr-10.1177_15459683221146995.tiff">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
                <p>Supplemental material, sj-tiff-3-nnr-10.1177_15459683221146995 for Optimized Home
Rehabilitation Technology Reduces Upper Extremity Impairment Compared to a
Conventional Home Exercise Program: A Randomized, Controlled, Single-Blind Trial
in Subacute Stroke by Veronica A. Swanson, Christopher Johnson, Daniel K.
Zondervan, Nicole Bayus, Phylicia McCoy, BS, Yat Fung Joshua Ng, Jenna
Schindele, BS, David J. Reinkensmeyer and Susan Shaw in Neurorehabilitation and
Neural Repair</p>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <fn-group>
              <fn fn-type="COI-statement">
                <p>The author(s) declared the following potential conflicts of interest with respect
to the research, authorship, and/or publication of this article: David J.
Reinkensmeyer has a financial interest in Hocoma A.G. and Flint Rehabilitation
Devices LLC, companies that develop and sell rehabilitation devices. Flint
Rehabilitation Devices produces the FitMi sensor used in this study. The terms
of these arrangements have been reviewed and approved by the University of
California, Irvine, in accordance with its conflict-of-interest policies. Daniel
K. Zondervan has a financial interest in Flint Rehabilitation Devices, LLC. All
other authors declare that they have no competing interests.</p>
              </fn>
              <fn fn-type="financial-disclosure">
                <p><bold>Funding:</bold> The author(s) disclosed receipt of the following financial support for the
research, authorship, and/or publication of this article: Research reported in
this publication was supported by the National Institute on Aging of the
National Institutes of Health under Award Number R44AG059256 and the ICT Access
for Mobile Rehabilitation (mRehab) Rehabilitation Engineering Research Center,
National Institute of Independent Living, Disability, and Rehabilitation
Research, 90REGE0011. The content is solely the responsibility of the authors
and does not necessarily represent the official views of the National Institutes
of Health.</p>
              </fn>
              <fn fn-type="other">
                <p><bold>ORCID iD:</bold> Veronica A. Swanson <inline-graphic xlink:href="10.1177_15459683221146995-img1.jpg"/>
<ext-link xlink:href="https://orcid.org/0000-0003-4004-9397" ext-link-type="uri">https://orcid.org/0000-0003-4004-9397</ext-link></p>
              </fn>
              <fn fn-type="supplementary-material">
                <p>Supplementary material for this article is available on the
<italic toggle="yes">Neurorehabilitation &amp; Neural Repair</italic> website along with
the online version of this article.</p>
              </fn>
            </fn-group>
            <ref-list>
              <title>References</title>
              <ref id="bibr1-15459683221146995">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobkin</surname><given-names>BH.</given-names></name></person-group><article-title>Strategies for stroke rehabilitation</article-title>.
<source>Lancet Neurol</source>.
<year>2004</year>;<volume>3</volume>(<issue>9</issue>):<fpage>528</fpage>-<lpage>536</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(04)00851-8</pub-id><pub-id pub-id-type="pmid">15324721</pub-id></mixed-citation>
              </ref>
              <ref id="bibr2-15459683221146995">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>L</given-names></name><name><surname>Flynn</surname><given-names>S.</given-names></name></person-group><article-title>A systematic review of the incidence, prevalence, costs, and
activity and work limitations of amputation, osteoarthritis, rheumatoid
arthritis, back pain, multiple sclerosis, spinal cord injury, stroke, and
traumatic brain injury in the United States: a 2019 update</article-title>.
<source>Arch Phys Med Rehabil</source>.
<year>2021</year>;<volume>102</volume>(<issue>1</issue>):<fpage>115</fpage>-<lpage>131</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2020.04.001</pub-id><pub-id pub-id-type="pmid">32339483</pub-id></mixed-citation>
              </ref>
              <ref id="bibr3-15459683221146995">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Benjamin</surname><given-names>EJ</given-names></name><name><surname>Muntner</surname><given-names>P</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Heart disease and stroke
statistics-2019 update: a report from the American Heart
Association</article-title>. <source>Circulation</source>.
<year>2019</year>;<volume>139</volume>(<issue>10</issue>):e56-e528.
doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000659</pub-id></mixed-citation>
              </ref>
              <ref id="bibr4-15459683221146995">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaki</surname><given-names>L.</given-names></name></person-group><article-title>Use-dependent plasticity of the human motor cortex in health and
disease</article-title>. <source>IEEE Eng Med Biol Mag Q Mag Eng Med Biol
Soc</source>.
<year>2005</year>;<volume>24</volume>(<issue>1</issue>):<fpage>36</fpage>-<lpage>39</lpage>.
doi:<pub-id pub-id-type="doi">10.1109/memb.2005.1384098</pub-id></mixed-citation>
              </ref>
              <ref id="bibr5-15459683221146995">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ada</surname><given-names>L</given-names></name><name><surname>Dorsch</surname><given-names>S</given-names></name><name><surname>Canning</surname><given-names>CG.</given-names></name></person-group><article-title>Strengthening interventions increase strength and improve
activity after stroke: a systematic review</article-title>. <source>Aust J
Physiother</source>.
<year>2006</year>;<volume>52</volume>(<issue>4</issue>):<fpage>241</fpage>-<lpage>248</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/s0004-9514(06)70003-4</pub-id><pub-id pub-id-type="pmid">17132118</pub-id></mixed-citation>
              </ref>
              <ref id="bibr6-15459683221146995">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Lee</surname><given-names>JH</given-names></name><name><surname>Snels</surname><given-names>IA</given-names></name><name><surname>Beckerman</surname><given-names>H</given-names></name><name><surname>Lankhorst</surname><given-names>GJ</given-names></name><name><surname>Wagenaar</surname><given-names>RC</given-names></name><name><surname>Bouter</surname><given-names>LM.</given-names></name></person-group><article-title>Exercise therapy for arm function in stroke patients: a
systematic review of randomized controlled trials</article-title>.
<source>Clin Rehabil</source>.
<year>2001</year>;<volume>15</volume>(<issue>1</issue>):<fpage>20</fpage>-<lpage>31</lpage>.
doi:<pub-id pub-id-type="doi">10.1191/026921501677557755</pub-id><pub-id pub-id-type="pmid">11237158</pub-id></mixed-citation>
              </ref>
              <ref id="bibr7-15459683221146995">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kloosterman</surname><given-names>MGM</given-names></name><name><surname>Snoek</surname><given-names>GJ</given-names></name><name><surname>Jannink</surname><given-names>MJA</given-names></name></person-group>. <article-title>Systematic review of the effects of exercise
therapy on the upper extremity of patients with spinal-cord
injury</article-title>. <source>Spinal Cord</source>.
<year>2009</year>;<volume>47</volume>(<issue>3</issue>):<fpage>196</fpage>-<lpage>203</lpage>.
doi:<pub-id pub-id-type="doi">10.1038/sc.2008.113</pub-id><pub-id pub-id-type="pmid">18825160</pub-id></mixed-citation>
              </ref>
              <ref id="bibr8-15459683221146995">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nudo</surname><given-names>RJ.</given-names></name></person-group><article-title>Postinfarct cortical plasticity and behavioral
recovery</article-title>. <source>Stroke</source>.
<year>2007</year>;<volume>38</volume>(<issue>2
Suppl</issue>):<fpage>840</fpage>-<lpage>845</lpage>. doi:<pub-id pub-id-type="doi">10.1161/01.STR.0000247943.12887.d2</pub-id><pub-id pub-id-type="pmid">17261749</pub-id></mixed-citation>
              </ref>
              <ref id="bibr9-15459683221146995">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>B</given-names></name><name><surname>Thomas</surname><given-names>LH</given-names></name><name><surname>Leathley</surname><given-names>MJ</given-names></name></person-group>, <etal>et al</etal>. <article-title>Repetitive task training for
improving functional ability after stroke</article-title>. <source>Cochrane
Database Syst Rev</source>. <year>2007</year>;<volume>4</volume>:CD006073.
doi:<pub-id pub-id-type="doi">10.1002/14651858.CD006073.pub2</pub-id></mixed-citation>
              </ref>
              <ref id="bibr10-15459683221146995">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dromerick</surname><given-names>AW</given-names></name><name><surname>Geed</surname><given-names>S</given-names></name><name><surname>Barth</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>Critical Period After Stroke
Study (CPASS): a phase II clinical trial testing an optimal time for motor
recovery after stroke in humans</article-title>. <source>Proc Natl Acad Sci
USA</source>.
<year>2021</year>;<volume>118</volume>(<issue>39</issue>):e2026676118.</mixed-citation>
              </ref>
              <ref id="bibr11-15459683221146995">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nudo</surname><given-names>RJ</given-names></name><name><surname>Plautz</surname><given-names>EJ</given-names></name><name><surname>Frost</surname><given-names>SB.</given-names></name></person-group><article-title>Role of adaptive plasticity in recovery of function after damage
to motor cortex</article-title>. <source>Muscle Nerve</source>.
<year>2001</year>;<volume>24</volume>(<issue>8</issue>):<fpage>1000</fpage>-<lpage>1019</lpage>.
doi:<pub-id pub-id-type="doi">10.1002/mus.1104</pub-id><pub-id pub-id-type="pmid">11439375</pub-id></mixed-citation>
              </ref>
              <ref id="bibr12-15459683221146995">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeffers</surname><given-names>MS</given-names></name><name><surname>Karthikeyan</surname><given-names>S</given-names></name><name><surname>Gomez-Smith</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Does stroke rehabilitation
really matter? Part B: an algorithm for prescribing an effective intensity
of rehabilitation</article-title>. <source>Neurorehabil Neural
Repair</source>.
<year>2018</year>;<volume>32</volume>(<issue>1</issue>):<fpage>73</fpage>-<lpage>83</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1545968317753074</pub-id><pub-id pub-id-type="pmid">29334831</pub-id></mixed-citation>
              </ref>
              <ref id="bibr13-15459683221146995">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lohse</surname><given-names>KR</given-names></name><name><surname>Lang</surname><given-names>CE</given-names></name><name><surname>Boyd</surname><given-names>LA.</given-names></name></person-group><article-title>Is more better? Using metadata to explore dose-response
relationships in stroke rehabilitation</article-title>.
<source>Stroke</source>.
<year>2014</year>;<volume>45</volume>(<issue>7</issue>):<fpage>2053</fpage>-<lpage>2058</lpage>.
doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.114.004695</pub-id><pub-id pub-id-type="pmid">24867924</pub-id></mixed-citation>
              </ref>
              <ref id="bibr14-15459683221146995">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klassen</surname><given-names>TD</given-names></name><name><surname>Dukelow</surname><given-names>SP</given-names></name><name><surname>Bayley</surname><given-names>MT</given-names></name></person-group>, <etal>et al</etal>. <article-title>Higher doses improve walking
recovery during stroke inpatient rehabilitation</article-title>.
<source>Stroke</source>.
<year>2020</year>;<volume>51</volume>(<issue>9</issue>):<fpage>2639</fpage>-<lpage>2648</lpage>.
doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.120.029245</pub-id><pub-id pub-id-type="pmid">32811378</pub-id></mixed-citation>
              </ref>
              <ref id="bibr15-15459683221146995">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Winstein</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>B</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Martinez</surname><given-names>C</given-names></name><name><surname>Schweighofer</surname><given-names>N.</given-names></name></person-group><article-title>Dosage matters</article-title>. <source>Stroke</source>.
<year>2019</year>;<volume>50</volume>(<issue>7</issue>):<fpage>1831</fpage>-<lpage>1837</lpage>.
doi:<pub-id pub-id-type="doi">10.1161/STROKEAHA.118.023603</pub-id><pub-id pub-id-type="pmid">31164067</pub-id></mixed-citation>
              </ref>
              <ref id="bibr16-15459683221146995">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang</surname><given-names>CE</given-names></name><name><surname>Macdonald</surname><given-names>JR</given-names></name><name><surname>Reisman</surname><given-names>DS</given-names></name></person-group>, <etal>et al</etal>. <article-title>Observation of amounts of
movement practice provided during stroke rehabilitation</article-title>.
<source>Arch Phys Med Rehabil</source>.
<year>2009</year>;<volume>90</volume>(<issue>10</issue>):<fpage>1692</fpage>-<lpage>1698</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.apmr.2009.04.005</pub-id><pub-id pub-id-type="pmid">19801058</pub-id></mixed-citation>
              </ref>
              <ref id="bibr17-15459683221146995">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proffitt</surname><given-names>R.</given-names></name></person-group><article-title>Home exercise programs for adults with neurological injuries: a
survey</article-title>. <source>Am J Occup Ther</source>.
<year>2016</year>;<volume>70</volume>(<issue>3</issue>):7003290020p1-7003290020p8.
doi:<pub-id pub-id-type="doi">10.5014/ajot.2016.019729</pub-id></mixed-citation>
              </ref>
              <ref id="bibr18-15459683221146995">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jurkiewicz</surname><given-names>MT</given-names></name><name><surname>Marzolini</surname><given-names>S</given-names></name><name><surname>Oh</surname><given-names>P.</given-names></name></person-group><article-title>Adherence to a home-based exercise program for individuals after
stroke</article-title>. <source>Top Stroke Rehabil</source>.
<year>2011</year>;<volume>18</volume>(<issue>3</issue>):<fpage>277</fpage>-<lpage>284</lpage>.
doi:<pub-id pub-id-type="doi">10.1310/tsr1803-277</pub-id><pub-id pub-id-type="pmid">21642065</pub-id></mixed-citation>
              </ref>
              <ref id="bibr19-15459683221146995">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>S.</given-names></name></person-group><article-title>The assessment of patient adherence to physiotherapy
rehabilitation</article-title>. <source>N Z J Physiother</source>.
<year>2003</year>;<volume>31</volume>:<fpage>60</fpage>-<lpage>66</lpage>.</mixed-citation>
              </ref>
              <ref id="bibr20-15459683221146995">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turton</surname><given-names>A</given-names></name><name><surname>Fraser</surname><given-names>C.</given-names></name></person-group><article-title>The use of home therapy programmes for improving recovery of the
upper limb following stroke</article-title>. <source>Br J Occup
Ther</source>.
<year>1990</year>;<volume>53</volume>(<issue>11</issue>):<fpage>457</fpage>-<lpage>462</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/030802269005301104</pub-id></mixed-citation>
              </ref>
              <ref id="bibr21-15459683221146995">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>KL</given-names></name><name><surname>Burke</surname><given-names>V</given-names></name><name><surname>Gorely</surname><given-names>TJ</given-names></name><name><surname>Beilin</surname><given-names>LJ</given-names></name><name><surname>Puddey</surname><given-names>IB.</given-names></name></person-group><article-title>Controlled comparison of retention and adherence in home- vs
center-initiated exercise interventions in women ages 40-65 years: the
S.W.E.A.T. Study (Sedentary Women Exercise Adherence Trial)</article-title>.
<source>Prev Med</source>.
<year>2003</year>;<volume>36</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>29</lpage>.
doi:<pub-id pub-id-type="doi">10.1006/pmed.2002.1134</pub-id><pub-id pub-id-type="pmid">12473421</pub-id></mixed-citation>
              </ref>
              <ref id="bibr22-15459683221146995">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rejeski</surname><given-names>WJ</given-names></name><name><surname>Brawley</surname><given-names>LR</given-names></name><name><surname>Ettinger</surname><given-names>W</given-names></name><name><surname>Morgan</surname><given-names>T</given-names></name><name><surname>Thompson</surname><given-names>C.</given-names></name></person-group><article-title>Compliance to exercise therapy in older participants with knee
osteoarthritis: implications for treating disability</article-title>.
<source>Med Sci Sports Exerc</source>.
<year>1997</year>;<volume>29</volume>(<issue>8</issue>):<fpage>977</fpage>-<lpage>985</lpage>.
doi:<pub-id pub-id-type="doi">10.1097/00005768-199708000-00001</pub-id><pub-id pub-id-type="pmid">9268953</pub-id></mixed-citation>
              </ref>
              <ref id="bibr23-15459683221146995">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sluijs</surname><given-names>EM</given-names></name><name><surname>Kok</surname><given-names>GJ</given-names></name><name><surname>van der Zee</surname><given-names>J.</given-names></name></person-group><article-title>Correlates of exercise compliance in physical
therapy</article-title>. <source>Phys Ther</source>.
<year>1993</year>;<volume>73</volume>(<issue>11</issue>):<fpage>771</fpage>-<lpage>782</lpage>;
discussion 783-786. doi:<pub-id pub-id-type="doi">10.1093/ptj/73.11.771</pub-id><pub-id pub-id-type="pmid">8234458</pub-id></mixed-citation>
              </ref>
              <ref id="bibr24-15459683221146995">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesse</surname><given-names>S</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Werner</surname><given-names>C.</given-names></name></person-group><article-title>Machines to support motor rehabilitation after stroke: 10 years
of experience in Berlin</article-title>. <source>J Rehabil Res Dev</source>.
<year>2006</year>;<volume>43</volume>(<issue>5</issue>):<fpage>671</fpage>-<lpage>678</lpage>.
doi:<pub-id pub-id-type="doi">10.1682/jrrd.2005.02.0052</pub-id><pub-id pub-id-type="pmid">17123207</pub-id></mixed-citation>
              </ref>
              <ref id="bibr25-15459683221146995">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>R</given-names></name><name><surname>Reinkensmeyer</surname><given-names>D</given-names></name><name><surname>Shah</surname><given-names>P</given-names></name></person-group>, <etal>et al</etal>. <article-title>Monitoring functional arm
movement for home-based therapy after stroke</article-title>. <source>Conf
Proc IEEE Eng Med Biol Soc</source>.
<year>2004</year>;<volume>2004</volume>:<fpage>4787</fpage>-<lpage>4790</lpage>.
doi:<pub-id pub-id-type="doi">10.1109/IEMBS.2004.1404325</pub-id><pub-id pub-id-type="pmid">17271381</pub-id></mixed-citation>
              </ref>
              <ref id="bibr26-15459683221146995">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zondervan</surname><given-names>DK</given-names></name><name><surname>Augsburger</surname><given-names>R</given-names></name><name><surname>Bodenhoefer</surname><given-names>B</given-names></name><name><surname>Friedman</surname><given-names>N</given-names></name><name><surname>Reinkensmeyer</surname><given-names>DJ</given-names></name><name><surname>Cramer</surname><given-names>SC.</given-names></name></person-group><article-title>Machine-based, self-guided home therapy for individuals with
severe arm impairment after stroke: a randomized controlled
trial</article-title>. <source>Neurorehabil Neural Repair</source>.
<year>2015</year>;<volume>29</volume>(<issue>5</issue>):<fpage>395</fpage>-<lpage>406</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1545968314550368</pub-id><pub-id pub-id-type="pmid">25273359</pub-id></mixed-citation>
              </ref>
              <ref id="bibr27-15459683221146995">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trialists</surname><given-names>OS.</given-names></name></person-group><article-title>Therapy-based rehabilitation services for stroke patients at
home</article-title>. <source>Cochrane Database Syst Rev</source>.
<year>2003</year>;<volume>1</volume>:CD002925. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD002925</pub-id></mixed-citation>
              </ref>
              <ref id="bibr28-15459683221146995">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laver</surname><given-names>KE</given-names></name><name><surname>Schoene</surname><given-names>D</given-names></name><name><surname>Crotty</surname><given-names>M</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Lannin</surname><given-names>NA</given-names></name><name><surname>Sherrington</surname><given-names>C.</given-names></name></person-group><article-title>Telerehabilitation services for stroke</article-title>.
<source>Cochrane Database Syst Rev</source>.
<year>2013</year>;<volume>12</volume>:CD010255. doi:<pub-id pub-id-type="doi">10.1002/14651858.CD010255.pub2</pub-id></mixed-citation>
              </ref>
              <ref id="bibr29-15459683221146995">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burridge</surname><given-names>JH</given-names></name><name><surname>Hughes</surname><given-names>AM.</given-names></name></person-group><article-title>Potential for new technologies in clinical
practice</article-title>. <source>Curr Opin Neurol</source>.
<year>2010</year>;<volume>23</volume>(<issue>6</issue>):<fpage>671</fpage>-<lpage>677</lpage>.
doi:<pub-id pub-id-type="doi">10.1097/WCO.0b013e3283402af5</pub-id><pub-id pub-id-type="pmid">20962639</pub-id></mixed-citation>
              </ref>
              <ref id="bibr30-15459683221146995">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brochard</surname><given-names>S</given-names></name><name><surname>Robertson</surname><given-names>J</given-names></name><name><surname>Médée</surname><given-names>B</given-names></name><name><surname>Rémy-Néris</surname><given-names>O.</given-names></name></person-group><article-title>What’s new in new technologies for upper extremity
rehabilitation?</article-title><source>Curr Opin Neurol</source>.
<year>2010</year>;<volume>23</volume>(<issue>6</issue>):<fpage>683</fpage>-<lpage>687</lpage>.
doi:<pub-id pub-id-type="doi">10.1097/WCO.0b013e32833f61ce</pub-id><pub-id pub-id-type="pmid">20852420</pub-id></mixed-citation>
              </ref>
              <ref id="bibr31-15459683221146995">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zondervan</surname><given-names>DK</given-names></name><name><surname>Smith</surname><given-names>B</given-names></name><name><surname>Reinkensmeyer</surname><given-names>DJ.</given-names></name></person-group><article-title>Lever-actuated resonance assistance (LARA): a wheelchair-based
method for upper extremity therapy and overground ambulation for people with
severe arm impairment</article-title>. <source>IEEE Int Conf Rehabil Robot
Proc</source>.
<year>2013</year>;<volume>2013</volume>:<fpage>6650400</fpage>. doi:<pub-id pub-id-type="doi">10.1109/ICORR.2013.6650400</pub-id></mixed-citation>
              </ref>
              <ref id="bibr32-15459683221146995">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>N</given-names></name><name><surname>Rowe</surname><given-names>JB</given-names></name><name><surname>Reinkensmeyer</surname><given-names>D</given-names></name><name><surname>Bachman</surname><given-names>M.</given-names></name></person-group><article-title>The Manumeter: a wearable device for monitoring daily use of the
wrist and fingers</article-title>. <source>IEEE J Biomed Health
Inform</source>.
<year>2014</year>;<volume>18</volume>:<fpage>1804</fpage>-<lpage>1812</lpage>.
doi:<pub-id pub-id-type="doi">10.1109/JBHI.2014.2329841</pub-id><pub-id pub-id-type="pmid">25014974</pub-id></mixed-citation>
              </ref>
              <ref id="bibr33-15459683221146995">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Abel</surname><given-names>KT</given-names></name><name><surname>Janecek</surname><given-names>JT</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>K</given-names></name><name><surname>Cramer</surname><given-names>SC.</given-names></name></person-group><article-title>Home-based technologies for stroke rehabilitation: a systematic
review</article-title>. <source>Int J Med Inf</source>.
<year>2019</year>;<volume>123</volume>:<fpage>11</fpage>-<lpage>22</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.ijmedinf.2018.12.001</pub-id></mixed-citation>
              </ref>
              <ref id="bibr34-15459683221146995">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Fu</surname><given-names>Q</given-names></name><name><surname>Tyson</surname><given-names>S</given-names></name><name><surname>Preston</surname><given-names>N</given-names></name><name><surname>Weightman</surname><given-names>A.</given-names></name></person-group><article-title>A scoping review of design requirements for a home-based upper
limb rehabilitation robot for stroke</article-title>. <source>Top Stroke
Rehabil</source>.
<year>2022</year>;<volume>29</volume>(<issue>0</issue>):<fpage>449</fpage>-<lpage>463</lpage>.
doi:<pub-id pub-id-type="doi">10.1080/10749357.2021.1943797</pub-id><pub-id pub-id-type="pmid">34281494</pub-id></mixed-citation>
              </ref>
              <ref id="bibr35-15459683221146995">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavuoto</surname><given-names>LA</given-names></name><name><surname>Subryan</surname><given-names>H</given-names></name><name><surname>Stafford</surname><given-names>M</given-names></name></person-group>, <etal>et al</etal>. <article-title>Understanding user
requirements for the design of a home-based stroke rehabilitation
system</article-title>. <source>Proc Hum Factors Ergon Soc Annu
Meet</source>.
<year>2018</year>;<volume>62</volume>(<issue>1</issue>):<fpage>1037</fpage>-<lpage>1041</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1541931218621239</pub-id><pub-id pub-id-type="pmid">35465216</pub-id></mixed-citation>
              </ref>
              <ref id="bibr36-15459683221146995">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daponte</surname><given-names>P</given-names></name><name><surname>De Vito</surname><given-names>L</given-names></name><name><surname>Riccio</surname><given-names>M</given-names></name><name><surname>Sementa</surname><given-names>C.</given-names></name></person-group><article-title>Design and validation of a motion-tracking system for ROM
measurements in home rehabilitation</article-title>.
<source>Measurement</source>.
<year>2014</year>;<volume>55</volume>:<fpage>82</fpage>-<lpage>96</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.measurement.2014.04.021</pub-id></mixed-citation>
              </ref>
              <ref id="bibr37-15459683221146995">
                <label>37</label>
                <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Egglestone</surname><given-names>SR</given-names></name><name><surname>Axelrod</surname><given-names>L</given-names></name><name><surname>Nind</surname><given-names>T</given-names></name></person-group>, <etal>et al</etal>. <article-title>A design framework for a
home-based stroke rehabilitation system: identifying the key
components</article-title>. <conf-name>2009 3rd International Conference on
Pervasive Computing Technologies for Healthcare, London, UK</conf-name>;
<year>2009</year>:<fpage>1</fpage>-<lpage>8</lpage>. doi:<pub-id pub-id-type="doi">10.4108/ICST.PERVASIVEHEALTH2009.6049</pub-id></mixed-citation>
              </ref>
              <ref id="bibr38-15459683221146995">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Axelrod</surname><given-names>L</given-names></name><name><surname>Fitzpatrick</surname><given-names>G</given-names></name><name><surname>Burridge</surname><given-names>J</given-names></name></person-group>, <etal>et al</etal>. <article-title>The reality of homes fit for
heroes: design challenges for rehabilitation technology at
home</article-title>. <source>J Assist Technol</source>.
<year>2009</year>;<volume>3</volume>(<issue>2</issue>):<fpage>35</fpage>-<lpage>43</lpage>.
doi:<pub-id pub-id-type="doi">10.1108/17549450200900014</pub-id></mixed-citation>
              </ref>
              <ref id="bibr39-15459683221146995">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasr</surname><given-names>N</given-names></name><name><surname>Leon</surname><given-names>B</given-names></name><name><surname>Mountain</surname><given-names>G</given-names></name></person-group>, <etal>et al</etal>. <article-title>The experience of living
with stroke and using technology: opportunities to engage and co-design with
end users</article-title>. <source>Disabil Rehabil Assist Technol</source>.
<year>2016</year>;<volume>11</volume>(<issue>8</issue>):<fpage>653</fpage>-<lpage>660</lpage>.
doi:<pub-id pub-id-type="doi">10.3109/17483107.2015.1036469</pub-id><pub-id pub-id-type="pmid">25879304</pub-id></mixed-citation>
              </ref>
              <ref id="bibr40-15459683221146995">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amirabdollahian</surname><given-names>F</given-names></name><name><surname>Ates</surname><given-names>S</given-names></name><name><surname>Basteris</surname><given-names>A</given-names></name></person-group>, <etal>et al</etal>. <article-title>Design, development and
deployment of a hand/wrist exoskeleton for home-based rehabilitation after
stroke - SCRIPT project</article-title>. <source>Robotica</source>.
<year>2014</year>;<volume>32</volume>(<issue>8</issue>):<fpage>1331</fpage>-<lpage>1346</lpage>.
doi:<pub-id pub-id-type="doi">10.1017/S0263574714002288</pub-id></mixed-citation>
              </ref>
              <ref id="bibr41-15459683221146995">
                <label>41</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Harley</surname><given-names>L</given-names></name><name><surname>Robertson</surname><given-names>S</given-names></name><name><surname>Gandy</surname><given-names>M</given-names></name><name><surname>Harbert</surname><given-names>S</given-names></name><name><surname>Britton</surname><given-names>D</given-names></name></person-group>. <part-title>The design of an interactive stroke
rehabilitation gaming system</part-title>. In: <person-group person-group-type="editor"><name><surname>Jacko</surname><given-names>JA</given-names></name></person-group>, ed. <source>Human-Computer Interaction. Users and
Applications</source>. Lecture Notes in Computer Science.
<publisher-name>Springer</publisher-name>;
<year>2011</year>:<fpage>167</fpage>-<lpage>173</lpage>. doi:<pub-id pub-id-type="doi">10.1007/978-3-642-21619-0_22</pub-id></mixed-citation>
              </ref>
              <ref id="bibr42-15459683221146995">
                <label>42</label>
                <mixed-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Balaam</surname><given-names>M</given-names></name><name><surname>Rennick
Egglestone</surname><given-names>S</given-names></name><name><surname>Hughes</surname><given-names>AM</given-names></name></person-group>, <etal>et al</etal>. <article-title>Rehabilitation centred
design</article-title>. In: <conf-name>CHI ’10 Extended Abstracts on Human
Factors in Computing Systems. Association for Computing
Machinery</conf-name>, <conf-loc>Atlanta, GA, USA</conf-loc>,
<conf-date>April 10-15,
2010</conf-date>:<fpage>4583</fpage>-<lpage>4586</lpage>. <comment>Accessed
August 7, 2021</comment>. <pub-id pub-id-type="doi">10.1145/1753846.1754197</pub-id></mixed-citation>
              </ref>
              <ref id="bibr43-15459683221146995">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wildenbos</surname><given-names>GA</given-names></name><name><surname>Peute</surname><given-names>L</given-names></name><name><surname>Jaspers</surname><given-names>M.</given-names></name></person-group><article-title>Aging barriers influencing mobile health usability for older
adults: a literature based framework (MOLD-US)</article-title>. <source>Int
J Med Inf</source>.
<year>2018</year>;<volume>114</volume>:<fpage>66</fpage>-<lpage>75</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/j.ijmedinf.2018.03.012</pub-id></mixed-citation>
              </ref>
              <ref id="bibr44-15459683221146995">
                <label>44</label>
                <mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>J</given-names></name></person-group>. <source>Statistical Power Analysis for the Behavioral
Sciences</source>. <publisher-name>L. Erlbaum Associates</publisher-name>;
<year>1988</year>.</mixed-citation>
              </ref>
              <ref id="bibr45-15459683221146995">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feys</surname><given-names>HM</given-names></name><name><surname>De Weerdt</surname><given-names>WJ</given-names></name><name><surname>Selz</surname><given-names>BE</given-names></name></person-group>, <etal>et al</etal>. <article-title>Effect of a therapeutic
intervention for the hemiplegic upper limb in the acute phase after stroke:
a single-blind, randomized, controlled multicenter trial</article-title>.
<source>Stroke</source>.
<year>1998</year>;<volume>29</volume>(<issue>4</issue>):<fpage>785</fpage>-<lpage>792</lpage>.
doi:<pub-id pub-id-type="doi">10.1161/01.str.29.4.785</pub-id><pub-id pub-id-type="pmid">9550512</pub-id></mixed-citation>
              </ref>
              <ref id="bibr46-15459683221146995">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machin</surname><given-names>D.</given-names></name></person-group><article-title>Clinical trials: design, conduct, and analysis. Curtis L. Meinert
(1986) Monographs in epidemiology and biostatistics. Volume 8. Oxford
University Press. New York and Oxford. Pages 469. £55 ISBN
5035682</article-title>. <source>Hum Psychopharmacol Clin Exp</source>.
<year>1988</year>;<volume>3</volume>(<issue>2</issue>):<fpage>153</fpage>-<lpage>153</lpage>.
doi:<pub-id pub-id-type="doi">10.1002/hup.470030214</pub-id></mixed-citation>
              </ref>
              <ref id="bibr47-15459683221146995">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>See</surname><given-names>J</given-names></name><name><surname>Dodakian</surname><given-names>L</given-names></name><name><surname>Chou</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>A standardized approach to
the Fugl-Meyer assessment and its implications for clinical
trials</article-title>. <source>Neurorehabil Neural Repair</source>.
<year>2013</year>;<volume>27</volume>(<issue>8</issue>):<fpage>732</fpage>-<lpage>741</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1545968313491000</pub-id><pub-id pub-id-type="pmid">23774125</pub-id></mixed-citation>
              </ref>
              <ref id="bibr48-15459683221146995">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platz</surname><given-names>T</given-names></name><name><surname>Pinkowski</surname><given-names>C</given-names></name><name><surname>van Wijck</surname><given-names>F</given-names></name><name><surname>Kim</surname><given-names>IH</given-names></name><name><surname>di Bella</surname><given-names>P</given-names></name><name><surname>Johnson</surname><given-names>G.</given-names></name></person-group><article-title>Reliability and validity of arm function assessment with
standardized guidelines for the Fugl-Meyer test, action research arm test
and box and block test: a multicentre study</article-title>. <source>Clin
Rehabil</source>.
<year>2005</year>;<volume>19</volume>(<issue>4</issue>):<fpage>404</fpage>-<lpage>411</lpage>.
doi:<pub-id pub-id-type="doi">10.1191/0269215505cr832oa</pub-id><pub-id pub-id-type="pmid">15929509</pub-id></mixed-citation>
              </ref>
              <ref id="bibr49-15459683221146995">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collen</surname><given-names>FM</given-names></name><name><surname>Wade</surname><given-names>DT</given-names></name><name><surname>Bradshaw</surname><given-names>CM.</given-names></name></person-group><article-title>Mobility after stroke: reliability of measures of impairment and
disability</article-title>. <source>Int Disabil Stud</source>.
<year>1990</year>;<volume>12</volume>(<issue>1</issue>):<fpage>6</fpage>-<lpage>9</lpage>.
doi:<pub-id pub-id-type="doi">10.3109/03790799009166594</pub-id><pub-id pub-id-type="pmid">2211468</pub-id></mixed-citation>
              </ref>
              <ref id="bibr50-15459683221146995">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohannon</surname><given-names>RW</given-names></name><name><surname>Smith</surname><given-names>MB.</given-names></name></person-group><article-title>Interrater reliability of a modified Ashworth scale of muscle
spasticity</article-title>. <source>Phys Ther</source>.
<year>1987</year>;<volume>67</volume>(<issue>2</issue>):<fpage>206</fpage>-<lpage>207</lpage>.
doi:<pub-id pub-id-type="doi">10.1093/ptj/67.2.206</pub-id><pub-id pub-id-type="pmid">3809245</pub-id></mixed-citation>
              </ref>
              <ref id="bibr51-15459683221146995">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Lee</surname><given-names>JH</given-names></name><name><surname>Beckerman</surname><given-names>H</given-names></name><name><surname>Knol</surname><given-names>DL</given-names></name><name><surname>de Vet</surname><given-names>HCW</given-names></name><name><surname>Bouter</surname><given-names>LM.</given-names></name></person-group><article-title>Clinimetric properties of the motor activity log for the
assessment of arm use in hemiparetic patients</article-title>.
<source>Stroke</source>.
<year>2004</year>;<volume>35</volume>(<issue>6</issue>):<fpage>1410</fpage>-<lpage>1414</lpage>.
doi:<pub-id pub-id-type="doi">10.1161/01.STR.0000126900.24964.7e</pub-id><pub-id pub-id-type="pmid">15087552</pub-id></mixed-citation>
              </ref>
              <ref id="bibr52-15459683221146995">
                <label>52</label>
                <mixed-citation publication-type="gov"><collab>Calculating the U.S. Population-based EQ-5D Index Score | AHRQ
Archive</collab>. <comment>2005. Accessed June 30, 2021</comment>. <ext-link xlink:href="https://archive.ahrq.gov/professionals/clinicians-providers/resources/rice/EQ5Dscore.html" ext-link-type="uri">https://archive.ahrq.gov/professionals/clinicians-providers/resources/rice/EQ5Dscore.html</ext-link></mixed-citation>
              </ref>
              <ref id="bibr53-15459683221146995">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>JW</given-names></name><name><surname>Johnson</surname><given-names>JA</given-names></name><name><surname>Coons</surname><given-names>SJ.</given-names></name></person-group><article-title>US valuation of the EQ-5D health states: development and testing
of the D1 valuation model</article-title>. <source>Med Care</source>.
<year>2005</year>;<volume>43</volume>(<issue>3</issue>):<fpage>203</fpage>-<lpage>220</lpage>.
doi:<pub-id pub-id-type="doi">10.1097/00005650-200503000-00003</pub-id><pub-id pub-id-type="pmid">15725977</pub-id></mixed-citation>
              </ref>
              <ref id="bibr54-15459683221146995">
                <label>54</label>
                <mixed-citation publication-type="webpage"><collab>Intrinsic Motivation Inventory (IMI) –
selfdeterminationtheory.org</collab>. <comment>Accessed March 24,
2021</comment>. <ext-link xlink:href="https://selfdeterminationtheory.org/intrinsic-motivation-inventory/" ext-link-type="uri">https://selfdeterminationtheory.org/intrinsic-motivation-inventory/</ext-link></mixed-citation>
              </ref>
              <ref id="bibr55-15459683221146995">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stekhoven</surname><given-names>DJ</given-names></name><name><surname>Buhlmann</surname><given-names>P.</given-names></name></person-group><article-title>MissForest: non-parametric missing value imputation for
mixed-type data</article-title>. <source>Bioinformatics</source>.
<year>2012</year>;<volume>28</volume>(<issue>1</issue>):<fpage>112</fpage>-<lpage>118</lpage>.
doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btr597</pub-id><pub-id pub-id-type="pmid">22039212</pub-id></mixed-citation>
              </ref>
              <ref id="bibr56-15459683221146995">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkenmeier</surname><given-names>RL</given-names></name><name><surname>Prager</surname><given-names>EM</given-names></name><name><surname>Lang</surname><given-names>CE.</given-names></name></person-group><article-title>Translating animal doses of task-specific training to people with
chronic stroke in one hour therapy sessions: a proof-of-concept
study</article-title>. <source>Neurorehabil Neural Repair</source>.
<year>2010</year>;<volume>24</volume>(<issue>7</issue>):<fpage>620</fpage>-<lpage>635</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1545968310361957</pub-id><pub-id pub-id-type="pmid">20424192</pub-id></mixed-citation>
              </ref>
              <ref id="bibr57-15459683221146995">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeMets</surname><given-names>DL</given-names></name><name><surname>Lan</surname><given-names>KK.</given-names></name></person-group><article-title>Interim analysis: the alpha spending function
approach</article-title>. <source>Stat Med</source>.
<year>1994</year>;<volume>13</volume>(<issue>13-14</issue>):<fpage>1341</fpage>-<lpage>1352</lpage>;
discussion 1353-1356. doi:<pub-id pub-id-type="doi">10.1002/sim.4780131308</pub-id><pub-id pub-id-type="pmid">7973215</pub-id></mixed-citation>
              </ref>
              <ref id="bibr58-15459683221146995">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lundquist</surname><given-names>CB</given-names></name><name><surname>Maribo</surname><given-names>T.</given-names></name></person-group><article-title>The Fugl–Meyer assessment of the upper extremity: reliability,
responsiveness and validity of the Danish version</article-title>.
<source>Disabil Rehabil</source>.
<year>2017</year>;<volume>39</volume>(<issue>9</issue>):<fpage>934</fpage>-<lpage>939</lpage>.
doi:<pub-id pub-id-type="doi">10.3109/09638288.2016.1163422</pub-id><pub-id pub-id-type="pmid">27062881</pub-id></mixed-citation>
              </ref>
              <ref id="bibr59-15459683221146995">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arya</surname><given-names>KN</given-names></name><name><surname>Verma</surname><given-names>R</given-names></name><name><surname>Garg</surname><given-names>RK.</given-names></name></person-group><article-title>Estimating the minimal clinically important difference of an
upper extremity recovery measure in subacute stroke
patients</article-title>. <source>Top Stroke Rehabil</source>.
<year>2011</year>;<volume>18</volume>(<issue>1</issue>):<fpage>599</fpage>-<lpage>610</lpage>.
doi:<pub-id pub-id-type="doi">10.1310/tsr18s01-599</pub-id><pub-id pub-id-type="pmid">22120029</pub-id></mixed-citation>
              </ref>
              <ref id="bibr60-15459683221146995">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Page</surname><given-names>SJ</given-names></name><name><surname>Fulk</surname><given-names>GD</given-names></name><name><surname>Boyne</surname><given-names>P.</given-names></name></person-group><article-title>Clinically important differences for the upper-extremity
Fugl-Meyer Scale in people with minimal to moderate impairment due to
chronic stroke</article-title>. <source>Phys Ther</source>.
<year>2012</year>;<volume>92</volume>(<issue>6</issue>):<fpage>791</fpage>-<lpage>798</lpage>.
doi:<pub-id pub-id-type="doi">10.2522/ptj.20110009</pub-id><pub-id pub-id-type="pmid">22282773</pub-id></mixed-citation>
              </ref>
              <ref id="bibr61-15459683221146995">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davidson</surname><given-names>I</given-names></name><name><surname>Hillier</surname><given-names>VF.</given-names></name></person-group><article-title>Comparison of four methods of allocation for clinical trials with
small sample sizes</article-title>. <source>Physiotherapy</source>.
<year>2002</year>;<volume>88</volume>(<issue>12</issue>):<fpage>722</fpage>-<lpage>729</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/S0031-9406(05)60715-8</pub-id></mixed-citation>
              </ref>
              <ref id="bibr62-15459683221146995">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boyd</surname><given-names>LA</given-names></name><name><surname>Hayward</surname><given-names>KS</given-names></name><name><surname>Ward</surname><given-names>NS</given-names></name></person-group>, <etal>et al</etal>. <article-title>Biomarkers of stroke
recovery: consensus-based core recommendations from the stroke recovery and
rehabilitation roundtable</article-title>. <source>Int J Stroke</source>.
<year>2017</year>;<volume>12</volume>(<issue>5</issue>):<fpage>480</fpage>-<lpage>493</lpage>.
doi:<pub-id pub-id-type="doi">10.1177/1747493017714176</pub-id><pub-id pub-id-type="pmid">28697711</pub-id></mixed-citation>
              </ref>
              <ref id="bibr63-15459683221146995">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stinear</surname><given-names>CM.</given-names></name></person-group><article-title>Prediction of motor recovery after stroke: advances in
biomarkers</article-title>. <source>Lancet Neurol</source>.
<year>2017</year>;<volume>16</volume>(<issue>10</issue>):<fpage>826</fpage>-<lpage>836</lpage>.
doi:<pub-id pub-id-type="doi">10.1016/S1474-4422(17)30283-1</pub-id><pub-id pub-id-type="pmid">28920888</pub-id></mixed-citation>
              </ref>
              <ref id="bibr64-15459683221146995">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swanson</surname><given-names>VA</given-names></name><name><surname>Chan</surname><given-names>V</given-names></name><name><surname>Cruz-Coble</surname><given-names>B</given-names></name></person-group>, <etal>et al</etal>. <article-title>A pilot study of a sensor
enhanced activity management system for promoting home rehabilitation
exercise performed during the COVID-19 pandemic: therapist experience,
reimbursement, and recommendations for implementation</article-title>.
<source>Int J Environ Res Public Health</source>.
<year>2021</year>;<volume>18</volume>(<issue>19</issue>):<fpage>10186</fpage>.
doi:<pub-id pub-id-type="doi">10.3390/ijerph181910186</pub-id><pub-id pub-id-type="pmid">34639494</pub-id></mixed-citation>
              </ref>
              <ref id="bibr65-15459683221146995">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos Muñoz</surname><given-names>EDJ</given-names></name><name><surname>Swanson</surname><given-names>VA</given-names></name><name><surname>Johnson</surname><given-names>C</given-names></name></person-group>, <etal>et al</etal>. <article-title>Using large-scale sensor
data to test factors predictive of perseverance in home movement
rehabilitation: optimal challenge and steady engagement</article-title>.
<source>Front Neurol</source>.
<year>2022</year>;<volume>13</volume>:<fpage>896298</fpage>.
<comment>Accessed June 21, 2022</comment>. <ext-link xlink:href="https://www.frontiersin.org/article/10.3389/fneur.2022.896298" ext-link-type="uri">https://www.frontiersin.org/article/10.3389/fneur.2022.896298</ext-link><pub-id pub-id-type="pmid">35795800</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
